Navigation Links
ACLU Challenges Patents on Breast Cancer Genes
Date:5/12/2009

Gene Patents Stifle Patient Access To Medical Care And Critical Research

NEW YORK, May 12 /PRNewswire-USNewswire/ -- The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes associated with breast and ovarian cancer stifle research that could lead to cures and limit women's options regarding their medical care. Mutations along the genes, known as BRCA1 and BRCA2, are responsible for most cases of hereditary breast and ovarian cancers. The lawsuit argues that the patents on these genes are unconstitutional and invalid.

"Knowledge about our own bodies and the ability to make decisions about our health care are some of our most personal and fundamental rights," said Anthony D. Romero, Executive Director of the ACLU. "The government should not be granting private entities control over something as personal and basic to who we are as our genes. Moreover, granting patents that limit scientific research, learning and the free flow of information violates the First Amendment."

Today's lawsuit was filed in U.S. District Court for the Southern District of New York on behalf of breast cancer and women's health groups, individual women and scientific associations representing approximately 150,000 researchers, pathologists and laboratory professionals against the U.S. Patent and Trademark Office (PTO), as well as Myriad Genetics and the University of Utah Research Foundation, which hold the patents on the BRCA genes. It is the first to apply the First Amendment to a gene patent challenge.

The patents granted to Myriad give the company the exclusive right to perform diagnostic tests on the BRCA1 and BRCA2 genes and to prevent any researcher from even looking at the genes without first getting permission from Myriad. According to the lawsuit, such monopolistic control over th
'/>"/>

SOURCE American Civil Liberties Union
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Actuaries: Trustees Reports Warn of Looming Financial Challenges Facing Retirement Programs
2. Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes
3. Filters Fast Challenges Universities and Colleges to Kick the Bottled Water Habit
4. Monell Center receives $100,000 Grand Challenges Explorations grant
5. Enormous Recovery Challenges Remain in Myanmar One Year After Cyclone Nargis
6. Aleres Dr. Gordon Norman Highlights Challenges and Promising Solutions to U.S. Healthcare System to International Health Insurance Executives
7. Skin and Bones Miss Universe Underscores On-Going Challenges of Eating Disorders Epidemic
8. Payment reform and solutions to challenges facing primary care addressed in policy papers
9. FRCs Tony Perkins Challenges Sebelius Integrity, Deep Ties to Late-Term Abortionist George Tiller
10. Good News for Tough Times: Small, Private University Responds to Todays Economic Challenges
11. PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 1SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 2SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 3California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 1California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 2California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 3California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 4Cell Therapeutics Inc 28CTI 29 to Present at BioCenturys NewsMakers in the Biotech Industry Conference 13959 1